Professor, Medicine and Pharmacology, Uniformed Services University SOM Director, Division of Clinical Pharmacology and Medical Toxicology
Internal Medicine
Dr. Louis R. Cantilena Jr., MD
|
|
Give Review
Louis Cantilena is an expert in the field of Internal Medicine. He attended University of Kansas School of Medicine. Louis Cantilena is a published doctor. He has 59 publications published. The most current publication "The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: a meta-analysis."
Publications
- Evidence-based evaluation of potential benefits and safety of beta-alanine supplementation for military personnel.
- A review of pharmaceutical labeling for overdose treatment and toxicity data.
- 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.
- Assessment of the Relative Potency of Fentanyl Buccal Tablet to Intravenous Morphine in Healthy Volunteers Using a Thermally Induced Hyperalgesia Pain Model.
- Pharmacokinetic profiles of artesunate after single intravenous doses at 0.5, 1, 2, 4, and 8 mg/kg in healthy volunteers: a phase I study.
- A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in health...
- 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS).
- Prevalence of abnormal liver-associated enzymes in cocaine experienced adults versus healthy volunteers during phase 1 clinical trials.
- Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.
- Rapid determination of N,N-diethyl-m-toluamide and permethrin in human plasma by gas chromatography-mass spectrometry and pyridostigmine bromide by high-performance li...
- The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tad...
- Metabolism by N-acetyltransferase 1 in vitro and in healthy volunteers: a prototype for targeted inhibition.
- The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.
- Initial evaluation of N,N-diethyl-m-toluamide and permethrin absorption in human volunteers under stress conditions.
- Intravenous cocaine and QT variability.
- 2009 Annual Report of the American Association of Poison Control Centers'' National Poison Data System (NPDS): 27th Annual Report.
- 2008 Annual Report of the American Association of Poison Control Centers'' National Poison Data System (NPDS): 26th Annual Report.
- 2007 Annual Report of the American Association of Poison Control Centers'' National Poison Data System (NPDS): 25th Annual Report.
- Population variability in the pharmacokinetics of terfenadine: the case for a pseudo-polymorphism with clinical implications.
- Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
- Assessment and reporting of clinical pharmacology information in drug labeling.
- The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: a meta-analysis.
- Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency.
- A drug interaction between zafirlukast and theophylline.
- Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion.
- Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients.
- Clinical pharmacology of 9-aminocamptothecin.
- Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine.
- Survey of clinical pharmacology training in the United States and Canada.
- Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.
- Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram.
- The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans.
- Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.
- Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine.
- Polypharmacy. Pharmacokinetic perspectives.
- Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics.
- Antipyrine as a model drug substance to assess oxidative metabolism.
- Panic disorder in a patient taking oxaprozin.
- Procainamide-induced myasthenia-like weakness and dysphagia.
- The effect of repeated administration of several chelators on the distribution and excretion of cadmium.
- Isolated rat hepatocytes as a model system for screening chelators for use in cadmium intoxication.
- The effect of ethylenediaminetetraacetic acid (EDTA) and EDTA plus salicylate on acute cadmium toxicity and distribution.
- Alteration of tissue disposition of cadmium by chelating agents.
- The effect of chelating agents on the excretion of endogenous metals.
- The effect of diethyldithiocarbamate on brain uptake of cadmium.
- Decreased effectiveness of chelation therapy with time after acute cadmium poisoning.
- Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion, and distribution of cadmium.
- Cadmium toxicity and lipid peroxidation in isolated rat hepatocytes.
- Torsades de pointes occurring in association with terfenadine use.
- Enantiomeric analysis of terfenadine in rat plasma by HPLC.
- Diurnal and seasonal variation of five carotenoids measured in human serum.
- Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin.
- Mercury clearance from human plasma during in vitro dialysis: screening systems for chelating agents.
- Nitric oxide hemoglobin in patients receiving nitroglycerin as detected by electron paramagnetic resonance spectroscopy.
- Methanol potentiation of carbon tetrachloride-induced hepatotoxicity.
- High performance liquid chromatographic measurement of iothalamate in human serum and urine for evaluation of glomerular filtration rate.
- Drug-induced torsades de pointes and implications for drug development.
- 2010 Annual Report of the American Association of Poison Control Centers'' National Poison Data System (NPDS): 28th Annual Report.
Schools
University of Kansas School of Medicine
Dartmouth Hitchcock M C
Doctors Specialties
- Medical Toxicology
- Internal Medicine
Accepted Insurances
- Aetna
- Amerihealth
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- United Healthcare
- UPMC Health Plan
Education
-
Dartmouth-Hitchcock Medical Center -
University of Kansas School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Amirali Nader, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher A. Pickett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan M. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geoffrey J. Cole, MD |
|
|
Dr. Douglas D. Clarke, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jay H. Chung, MD |